Chronic Tinnitus study: Acoustic Stimulation
Official title Interventional Treatment of Chronic Tinnitus With Acoustic Stimulation
ClinicalTrials.gov ID: NCT07185061
What this study is testing
- What it's testing
- This study is testing whether a custom sound therapy helps reduce the ringing in your ears. It looks at how this treatment affects the brain's hearing pathways.
- Who it's for
- You may be able to join if you have had ringing in your ears for at least six months.
- What's involved
- You would listen to special sounds made just for you. These sounds are designed to help your brain filter out the ringing.
- Time commitment
- The source text does not say how long the study lasts or how many visits are needed.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Patients with chronic tinnitus lasting over six months (with or without hearing loss), showing no organic lesions in the auditory conduction pathway...
You likely can't join if
- Patients with organic lesions in the auditory conduction pathway and temporal bone (e.g., tympanic membrane perforation, ossicular chain disruption)...
The study team makes the final eligibility decision.
Where it is enrolling
- Nanjing, Jiangsu, China
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Nanjing, Jiangsu, China. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.